EL7.AI
StocksMedium•16 November 2026•
4 min read

Euronext Lists Exosens Announcement of Order for 25,000 Night-Vision Tubes

Key Facts

1On November 16, Euronext listed an Exosens announcement of an order for 25,000 image intensifier tubes.
2THEON’s revenue in the first nine months of 2026 rose 37.1% to 382.8 million euros.
3THEON’s orders in the first nine months rose 22.5% to 285.2 million euros.
4Exosens and THEON extended their supply agreement by 3 years in December 2025, with potential coverage through the end of 2030.

Euronext’s Paris market page listed a press release from Exosens on November 16, 2026, with a headline indicating a large order for 25,000 image intensifier tubes for night-vision devices. The announcement appeared at 07:15 Central European Time, according to Euronext’s company news log. The headline specifies the number of tubes and their purpose, but the page as opened does not provide details on the order’s terms or value. The information published there therefore does not confirm the options or delivery dates cited in the headline circulating elsewhere. The announcement comes as THEON, a company that works on night-vision solutions, reported strong growth in revenue and orders during the first nine months of the year.

THEON recorded revenue of 382.8 million euros in the first nine months of 2026, up 37.1% year on year, according to its trading update. The company said revenue growth came alongside a broader contribution from activities outside night vision, which accounted for 17.6% of revenue in the period, compared with 7.1% in the corresponding period of 2025. This points to greater product-mix diversification, with an increasing contribution from Kappa, which THEON identified as one of the growth drivers. In the third quarter alone, revenue rose 40.4% and the adjusted operating profit margin was 26.2%. These figures place demand for night-vision solutions in the context of THEON’s broader growth trajectory, without specifying the value of the Exosens order listed by Euronext.

THEON’s new orders also rose 22.5% in the first nine months of 2026 to 285.2 million euros compared with the same period of 2025. The company attributed sustained strong demand for night-vision solutions to programs to modernize soldiers’ equipment in NATO member and allied countries. This is THEON’s stated explanation for demand in the sector, but it does not on its own establish details of the contract Euronext listed under Exosens’s name. On October 20, 2026, THEON announced contracts for night-vision products worth a total of about 45 million euros from two European NATO member countries, subject to final approvals by the authorities. Deliveries were expected to begin that year, according to the company’s announcement.

Cooperation between Exosens and THEON includes a supply agreement extended in December 2025 for an additional 3 years, covering potential deliveries through the end of 2030. Exosens said THEON could purchase more than 400,000 tubes during the five years following the agreement, and described it as its largest customer for image intensifier tubes. A separate contract announced in late 2025 with the OCCAR organization covered 200,000 16-millimeter tubes for the German armed forces, valued at more than 500 million euros, with deliveries scheduled between 2027 and 2029. These agreements show the scale of contracts and production capacity associated with the night-vision sector, but remain separate background to the details of the announcement listed on November 16. Exosens has said its investment plan targets a 40% increase in production capacity by 2027 across its 16- and 18-millimeter and fifth-generation product families.

On its outlook, THEON reaffirmed revenue guidance of about 600 million euros for 2026 and set a baseline adjusted operating profit margin of 26%. The company cut its estimate for capital expenditure this year to about 25 million euros from about 30 million previously. It also raised its medium-term organic revenue growth target to more than 20% annually, from more than 15%. In its 2025 results, Exosens recorded revenue of 468.2 million euros, up 22.1% from 2024, with defense and surveillance accounting for 75% of group revenue. In February 2026, the company had forecast revenue of between 520 million and 540 million euros and adjusted earnings before interest, taxes, depreciation and amortization of between 168 million and 178 million euros.

THEON is scheduled to hold a live investor presentation on its third-quarter and first-nine-month 2026 results on November 18, at 2 p.m. Greenwich Mean Time, or 4 p.m. Eastern European Time. The event follows the company’s announcement of revenue growth and an increase in its medium-term target, while the Euronext page as opened provided no further details on the order attributed to Exosens. Regarding its products, Exosens said fifth-generation image intensifier technology improves overall performance by 30% and extends detection range by up to 35% compared with current standards. This comparison remains the company’s description of its technology and does not specify whether the tubes in the Euronext announcement are from this generation.